Michael J. Catelani - 05 Jan 2026 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
President, COO & CFO
Signature
/s/ Michael J. Catelani
Issuer symbol
ANIX
Transactions as of
05 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 19:41:04 UTC
Previous filing
15 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Catelani Michael President, COO & CFO C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, /s/ Michael J. Catelani 06 Jan 2026 0001689394

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Award $0 +175,000 $0.000000 175,000 05 Jan 2026 Common Stock 175,000 $3.18 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026.